Fish Oil for the Treatment of Cardiovascular Disease
Open accessThe DOI matches its Crossref record; 85 of the 88 references it cites were found in a registry or an index.
Abstract
Omega-3 fatty acids, which are found abundantly in fish oil, are increasingly being used in the management of cardiovascular disease. It is clear that fish oil, in clinically used doses (typically 4 g/d of eicosapentaenoic acid and docosahexaenoic acid) reduce high triglycerides. However, the role of omega-3 fatty acids in reducing mortality, sudden death, arrhythmias, myocardial infarction, and heart failure has not yet been established. This review will focus on the current clinical uses of fish oil and provide an update on their effects on triglycerides, coronary artery disease, heart failure, and arrhythmia. We will explore the dietary sources of fish oil as compared with drug therapy, and discuss the use of fish oil products in combination with other commonly used lipid-lowering agents. We will examine the underlying mechanism of fish oil's action on triglyceride reduction, plaque stability, and effect in diabetes, and review the newly discovered anti-inflammatory effects of fish oil. Finally, we will examine the limitations of current data and suggest recommendations for fish oil use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another issue is poor product quality and purity, including contaminants, cholesterol, saturated fats, and oxidation products (Figs. 1, 2) [57, 59–66].”
From Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review (2020) · cites this paper as [63]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2002) · Circulation · doi:10.1161/01.cir.0000038493.65177.94 · Cited by 3,707
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932 · cited 1×
“In recent years there has been a growing body of evidence that is shifting the paradigm of how inflammation is contained and dissipated.(4) In this new model, inflammation resolution is an active process mediated by lipid-derived compounds.”
Backgroundde Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Delaye, J., & Mamelle, N. (1999) · Circulation · doi:10.1161/01.cir.99.6.779 · Cited by 2,910
Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176158 · Cited by 2,705
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610 · cited 5×
“For patients without documented CAD, the American Heart Association 2006 Diet and Lifestyle Recommendations advise the consumption of at least 2 servings of fish per week, preferably fatty fish high in DHA and EPA.65 The guidelines also recommend a daily fish intake equivalent to 1 g/d of EPA and DHA for secondary pre…”
MethodInfluentialYokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease
de Lorgeril, M., Renaud, S., Salen, P., Monjaud, I., Mamelle, N., Martin, J. L., Guidollet, J., Touboul, P., & Delaye, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92580-1 · Cited by 2,122 · cited 1×
“The Lyon Diet Heart Study, performed shortly after the DART study, was a prospective trial of 607 survivors of MI who were randomized to either a Mediterranean diet or a regular Western diet.(49) At a mean follow-up of 27 months, the primary end point of death from cardiovascular causes and nonfatal deaths had a 73% r…”
Method(1999) · PubMed · Cited by 2,062
Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits
Mozaffarian, D., & Rimm, E. B. (2006) · JAMA · doi:10.1001/jama.296.15.1885 · Cited by 1,966 · cited 1×
“Dioxins, which do not have FDA action levels, are present in the majority of marine life.(66)”
BackgroundSerhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
n-3 fatty acids and serum lipoproteins: human studies
Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243 · cited 2×
“However, in patients with triglycerides 200 mg/dL, who are treated with 4 g/d of fish oil, a 30% reduction in triglycerides is expected.(17,69) For patients with triglycerides 500 mg/dL who are at risk for pancreatitis, the National Cholesterol Education Program Adult Treatment Panel III guidelines recommend using fis…”
BackgroundMethodBlood Levels of Long-Chain n–3 Fatty Acids and the Risk of Sudden Death
Albert, C. M., Campos, H., Stampfer, M. J., Ridker, P. M., Manson, J. E., Willett, W. C., & Ma, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012918 · Cited by 1,146 · cited 1×
“In the 119 patients that succumbed to sudden death, baseline omega-3 FA blood levels were significantly lower than in matched controls.(34) Finally, in an analysis of data from the Nurses Health Study, a cohort study of 84,688 women, an inverse association was shown between fish consumption and CAD-related death.”
ResultLipids and lipid metabolism in eukaryotic algae
Guschina, I. A., & Harwood, J. L. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.01.001 · Cited by 1,110 · cited 1×
“Humans are unable to place double bonds beyond position 9 on long chain polyunsaturated fatty acids (FA), making the omega-3 FA synthesized in plants and in marine microalgae essential elements to the human diet.(1) Fish contain high levels of 2 omega-3 FA, eicosapentaenoic acid (EPA; C20:5 n-3), and docosahexaenoic a…”
BackgroundFish and Omega-3 Fatty Acid Intake and Risk of Coronary Heart Disease in Women
Hu, F. B. (2002) · JAMA · doi:10.1001/jama.287.14.1815 · Cited by 1,018 · cited 1×
“The investigators concluded that the reduction in CAD deaths was likely due to a reduction in sudden deaths, as there was no difference in the rate of MI when comparing high and low fish consumption.(35) The randomized trials assessing the efficacy of fish oil supplementation on secondary prevention of CAD lend furthe…”
ResultHong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000
Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., & Serhan, C. N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042031 · Cited by 922
Siscovick, D. S. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530170043030 · Cited by 920 · cited 1×
“quartile, was associated with a relative risk reduction of 70%.(33) A similar finding was appreciated in a nested, prospective, case-control study of the Physician Health Study cohort of 22,000 healthy males.”
ResultThies, F., Garry, J. M., Yaqoob, P., Rerkasem, K., Williams, J., Shearman, C. P., Gallagher, P. J., Calder, P. C., & Grimble, R. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12468-3 · Cited by 739
Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review
Balk, E. M., Lichtenstein, A. H., Chung, M., Kupelnick, B., Chew, P., & Lau, J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.012 · Cited by 732 · cited 1×
“However, in patients with triglycerides 200 mg/dL, who are treated with 4 g/d of fish oil, a 30% reduction in triglycerides is expected.(17,69) For patients with triglycerides 500 mg/dL who are at risk for pancreatitis, the National Cholesterol Education Program Adult Treatment Panel III guidelines recommend using fis…”
BackgroundArita, M., Ohira, T., Sun, Y.-P., Elangovan, S., Chiang, N., & Serhan, C. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3912 · Cited by 633
Leaf, A., Kang, J. X., Xiao, Y.-F., & Billman, G. E. (2003) · Circulation · doi:10.1161/01.cir.0000069566.78305.33 · Cited by 605 · cited 1×
“It is hypothesized that during ischemia, a reduction in the sodium ion current protects hyperexcitable tissue, and a reduction in the calcium ion current reduces arrhythmogenic depolarizing currents.(30) Heart rate variability, a possible surrogate outcome for the risk of sudden death, was assessed in a randomized tri…”
Backgroundvon Schacky, C., Angerer, P., Kothny, W., Theisen, K., & Mudra, H. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-7-199904060-00003 · Cited by 487
Hasturk, H., Kantarci, A., Goguet-Surmenian, E., Blackwood, A., Andry, C., Serhan, C. N., & Van Dyke, T. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.7021 · Cited by 461
Fish Intake and Risk of Incident Atrial Fibrillation
Mozaffarian, D., Psaty, B. M., Rimm, E. B., Lemaitre, R. N., Burke, G. L., Lyles, M. F., Lefkowitz, D., & Siscovick, D. S. (2004) · Circulation · doi:10.1161/01.cir.0000138154.00779.a5 · Cited by 456 · cited 1×
“However, in a 12-year prospective, observational study of 4815 adults over the age of 65, daily fish consumption was associated with a 31% risk reduction in incident atrial fibrillation.(48)”
BackgroundHarris, W. S., Connor, W. E., & McMurry, M. P. (1983) · Metabolism · doi:10.1016/0026-0495(83)90226-3 · Cited by 420 · cited 1×
“high doses of omega-3 FA are used.(67,68) However, in patients with triglycerides 200 mg/dL, who are treated with 4 g/d of fish oil, a 30% reduction in triglycerides is expected.”
BackgroundKnapp, H. R., Reilly, I. A. G., Alessandrini, P., & FitzGerald, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604103141501 · Cited by 415
Davidson, M. H., Stein, E. A., Bays, H. E., Maki, K. C., Doyle, R. T., Shalwitz, R. A., Ballantyne, C. M., & Ginsberg, H. N. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.018 · Cited by 385
Xiao, Y.-F., Gomez, A. M., Morgan, J. P., Lederer, W. J., & Leaf, A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4182 · Cited by 384
Mechanisms for the Hypotriglyceridemic Effect of Marine Omega-3 Fatty Acids
Davidson, M. H. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.024 · Cited by 374
Raitt, M. H., Connor, W. E., Morris, C., Kron, J., Halperin, B., Chugh, S. S., McClelland, J., Cook, J., MacMurdy, K., Swenson, R., et al. (2005) · JAMA · doi:10.1001/jama.293.23.2884 · Cited by 371
Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake
Leaf, A., Albert, C. M., Josephson, M., Steinhaus, D., Kluger, J., Kang, J. X., Cox, B., Zhang, H., & Schoenfeld, D. (2005) · Circulation · doi:10.1161/circulationaha.105.549527 · Cited by 364 · cited 1×
“This finding was not replicated in a trial of 200 patients who were randomized to either fish oil or a placebo and followed for a median of approximately 2 years.(42) In fact, time to first ICD cardioversion was not changed and the incidence of recurrent ventricular tachycardia and fibrillation was more common in the…”
ResultOmega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance
Park, Y., & Harris, W. S. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200282-jlr200 · Cited by 348
Xiao, Y. F., Kang, J. X., Morgan, J. P., & Leaf, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11000 · Cited by 332
Weintraub, M. S., Zechner, R., Brown, A., Eisenberg, S., & Breslow, J. L. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113806 · Cited by 331 · cited 1×
“Fish oil may also accelerate VLDL and chylomicron clearance(21) by inducing lipoprotein lipase activity.(22)”
BackgroundSafety and Efficacy of Omacor in Severe Hypertriglyceridemia
Harris, W. S., Ginsberg, H. N., Arunakul, N., Shachter, N. S., Windsor, S. L., Adams, M., Berglund, L., & Osmundsen, K. (1997) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679700400511 · Cited by 306
Brouwer, I. A., Zock, P. L., Camm, A. J., Böcker, D., Hauer, R. N. W., Wever, E. F. D., Dullemeijer, C., Ronden, J. E., Katan, M. B., Lubinski, A., et al. (2006) · JAMA · doi:10.1001/jama.295.22.2613 · Cited by 287 · cited 1×
“In the largest trial, 546 patients were randomized to supplemental fish oil or a placebo and were followed for a mean period of 1 year.(43) The primary outcome of the rate of ICD cardioversion or all-cause mortality was not reduced.”
BackgroundOmega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus
Hartweg, J., Perera, R., Montori, V. M., Dinneen, S. F., Neil, A. H., & Farmer, A. J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003205.pub2 · Cited by 282 · cited 1×
“A recent comprehensive meta-analysis analyzed the effect of fish oil supplements on metabolic parameters when added to usual care in patients with type 2 diabetes mellitus or impaired glucose tolerance.(54) The meta-analysis included a total of 23 small, randomized trials with over 1000 patients that were assessed for…”
BackgroundEffect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency
Eritsland, J., Arnesen, H., Grønseth, K., Fjeld, N. B., & Abdelnoor, M. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89130-8 · Cited by 252 · cited 1×
“At 1 year, the number of bleeding complications was not increased.(15) The effect of fish oil on INR values has not been studied extensively, but a small, randomized trial showed that fish oil did not alter the Coumadin dosing regimen.”
BackgroundSafety and efficacy of Omacor in severe hypertriglyceridemia
Harris, W. S., Ginsberg, H. N., Arunakul, N., Shachter, N. S., Windsor, S. L., Adams, M., Berglund, L., & Osmundsen, K. (1997) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199710000-00011 · Cited by 252
Ariel, A., Li, P.-L., Wang, W., Tang, W.-X., Fredman, G., Hong, S., Gotlinger, K. H., & Serhan, C. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509796200 · Cited by 246 · cited 1×
“In addition, protectins can reduce tumor necrosis factor and interferon secretion.(13) Interestingly, both protectins and resolvins are strictly derived from omega-3 FA.”
BackgroundChristensen, J. H., Gustenhoff, P., Korup, E., Aaroe, J., Toft, E., Moller, T., Rasmussen, K., Dyerberg, J., & Schmidt, E. B. (1996) · BMJ · doi:10.1136/bmj.312.7032.677 · Cited by 244
Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids.
Billman, G. E., Hallaq, H., & Leaf, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4427 · Cited by 244
Fish oil supplementation in type 2 diabetes: a quantitative systematic review.
Montori, V. M., Farmer, A., Wollan, P. C., & Dinneen, S. F. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1407 · Cited by 242
Tjonahen, E., Oh, S. F., Siegelman, J., Elangovan, S., Percarpio, K. B., Hong, S., Arita, M., & Serhan, C. N. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.09.011 · Cited by 239 · cited 1×
“EPA is the substrate of the resolvins family and DHA can be converted to both resolvins and protectins.(7) It may be that the effects of fish oil on inflammatory mediators underlie the positive findings demonstrated in several trials assessing fish oil and plaque stability.”
BackgroundDietary fatty acids in human thrombosis and hemostasis
Knapp, H. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1687s · Cited by 239 · cited 1×
“The same trend, however, has not been clearly demonstrated in measurements of clotting times or in factors of fibrinolysis.(80) In addition, in randomized clinical trials of patients undergoing coronary artery bypass graft surgery, percutaneous transluminal coronary angioplasty, endarterectomy and diagnostic angiograp…”
BackgroundKang, J. X., & Leaf, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9886 · Cited by 237
Kang, J. X., Xiao, Y. F., & Leaf, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3997 · Cited by 227
Do fish oils prevent restenosis after coronary angioplasty?
Leaf, A., Jorgensen, M. B., Jacobs, A. K., Cote, G., Schoenfeld, D. A., Scheer, J., Weiner, B. H., Slack, J. D., Kellett, M. A., & Raizner, A. E. (1994) · Circulation · doi:10.1161/01.cir.90.5.2248 · Cited by 218
Expert Opinion: Omega-3 Fatty Acids and Bleeding—Cause for Concern?
Harris, W. S. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.021 · Cited by 191 · cited 1×
“In addition, in randomized clinical trials of patients undergoing coronary artery bypass graft surgery, percutaneous transluminal coronary angioplasty, endarterectomy and diagnostic angiography, no adverse bleeding related events have been demonstrated.(81) For example, in a trial of 500 patients randomized to pretrea…”
BackgroundMadsen, L., Rustan, A. C., Vaagenes, H., Berge, K., Dyrøy, E., & Berge, R. K. (1999) · Lipids · doi:10.1007/s11745-999-0445-x · Cited by 186
Suzukawa, M., Abbey, M., Howe, P. R., & Nestel, P. J. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39881-3 · Cited by 185
Brouwer, I. A., Heeringa, J., Geleijnse, J. M., Zock, P. L., & Witteman, J. C. M. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.07.029 · Cited by 174 · cited 1×
“The Danish Diet, Cancer and Health Study, and the Rotterdam Study followed 47,000 and 5100 middleaged adults, respectively.(45,46) Neither study found that the consumption of fish oil affected the incidence of atrial fibrillation.”
BackgroundFrost, L., & Vestergaard, P. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.50 · Cited by 173 · cited 1×
“The Danish Diet, Cancer and Health Study, and the Rotterdam Study followed 47,000 and 5100 middleaged adults, respectively.(45,46) Neither study found that the consumption of fish oil affected the incidence of atrial fibrillation.”
BackgroundMetabolic Inactivation of Resolvin E1 and Stabilization of Its Anti-inflammatory Actions
Arita, M., Oh, S. F., Chonan, T., Hong, S., Elangovan, S., Sun, Y.-P., Uddin, J., Petasis, N. A., & Serhan, C. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603766200 · Cited by 165
Clinical Overview of Omacor: A Concentrated Formulation of Omega-3 Polyunsaturated Fatty Acids
Bays, H. E. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.029 · Cited by 130 · cited 1×
“The official label recommendation for Lovaza is for patients with triglycerides 500 mg/dL.(73)”
BackgroundPan, M., Maitin, V., Parathath, S., Andreo, U., Lin, S. X., Germain, C. S., Yao, Z., Maxfield, F. R., Williams, K. J., & Fisher, E. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707460104 · Cited by 128 · cited 1×
“This effect occurs most likely through multiple mechanisms, including: (1) decreased synthesis of triglycerides because these omega-3 FA may not be the preferred substrates of the enzyme diacylglycerol O-acyltransferase,(18) or they may interact with nuclear transcription factors that control lipogenesis(19); cellular…”
BackgroundSelf-citationBrouwer, I. A., Raitt, M. H., Dullemeijer, C., Kraemer, D. F., Zock, P. L., Morris, C., Katan, M. B., Connor, W. E., Camm, J. A., Schouten, E. G., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehp003 · Cited by 120 · cited 1×
“It was concluded in a recent meta-analysis of these trials that fish oil did not have a protective effect.(44) The effect of fish oil on incident atrial fibrillation has not been studied in large randomized trials, and observational populationbased trials show mixed results.”
ResultMayer, K., Merfels, M., Muhly-Reinholz, M., Gokorsch, S., Rosseau, S., Lohmeyer, J., Schwarzer, N., Krüll, M., Suttorp, N., Grimminger, F., et al. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00235.2002 · Cited by 116 · cited 1×
“This warning is based on observational studies that suggested a prolonged bleeding time in populations ingesting high levels of fish oil(77) and on in vitro studies that demonstrated an effect on pro-thrombotic mediators such as a reduction in thromboxane A2 production(78) and platelet activation factor.(79) The same…”
BackgroundStalenhoef, A. F. H., Graaf, J. D., Wittekoek, M. E., Bredie, S. J. H., Demacker, P. N. M., & Kastelein, J. J. P. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00381-6 · Cited by 114
Contacos, C., Barter, P. J., & Sullivan, D. R. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.12.1755 · Cited by 113
Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses
Calabresi, L., Donati, D., Pazzucconi, F., Sirtori, C. R., & Franceschini, G. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00267-1 · Cited by 109
Nordøy, Bønaa, Nilsen, Berge, Hansen, & Ingebretsen (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00297.x · Cited by 103
Sirtori, C., Paoletti, R., Mancini, M., Crepaldi, G., Manzato, E., Rivellese, A. A., Pamparana, F., & Stragliotto, E. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.6.1874 · Cited by 93 · cited 1×
“The largest randomized trial to date assessed approximately 400 patients with impaired glucose tolerance or insulin-dependent diabetes mellitus, and as reflected in the larger meta-analysis, found no effect of moderate to high doses of fish oil on diabetic parameters.(55) There are insufficient randomized data to comm…”
ResultFactorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity
Chan, D. C., Watts, G. F., Mori, T. A., Barrett, P. H. R., Beilin, L. J., & Redgrave, T. G. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01001.x · Cited by 92
Gerber, J. G., Kitch, D. W., Fichtenbaum, C. J., Zackin, R. A., Charles, S., Hogg, E., Acosta, E. P., Connick, E., Wohl, D., Kojic, E. M., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31815bace2 · Cited by 85
Fish oil in people with type 2 diabetes mellitus
Farmer, A., Montori, V, Dinneen, S., & Clar, C. (2001) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003205 · Cited by 82
Coexpression with β1-subunit modifies the kinetics and fatty acid block of hH1αNa+channels
Xiao, Y.-F., Wright, S. N., Wang, G. K., Morgan, J. P., & Leaf, A. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.1.h35 · Cited by 80
Dietary Fish Intake and Incident Atrial Fibrillation (from the Women's Health Initiative)
Berry, J. D., Prineas, R. J., van Horn, L., Passman, R., Larson, J., Goldberger, J., Snetselaar, L., Tinker, L., Liu, K., & Lloyd-Jones, D. M. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.11.039 · Cited by 78 · cited 1×
“Similar findings were seen in the Women’s Health Initiative where there was no association between fish and omega-3 FA intake regarding incident atrial fibrillation.(47) However, in a 12-year prospective, observational study of 4815 adults over the age of 65, daily fish consumption was associated with a 31% risk reduc…”
ResultFish oils in hypertriglyceridemia: a dose-response study
Harris, W., Rothrock, D. W., Fanning, A., Inkeles, S. B., Sh, G., Illingworth, D. R., & CONNOR, W. E. (1990) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/51.3.399 · Cited by 78 · cited 1×
“high doses of omega-3 FA are used.(67,68) However, in patients with triglycerides 200 mg/dL, who are treated with 4 g/d of fish oil, a 30% reduction in triglycerides is expected.”
BackgroundBender, N., Kraynak, M., Chiquette, E., Linn, W., Clark, G. M., & Bussey, H. (1998) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1008852127668 · Cited by 67 · cited 1×
“The effect of fish oil on INR values has not been studied extensively, but a small, randomized trial showed that fish oil did not alter the Coumadin dosing regimen.(83) There is very little evidence that a lower target INR is necessary in patients receiving chronic warfarin therapy and fish oil.”
BackgroundVassiliou, E. K., Kesler, O. M., Tadros, J. H., & Ganea, D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4534 · Cited by 56
Secondary prevention of CHD in UK men: the Diet and Reinfarction Trial and its sequel
Burr, M. L. (2007) · Proceedings of the Nutrition Society · doi:10.1017/s0029665107005241 · Cited by 53 · cited 1×
“The Diet and Reinfarction Trial (DART),(37) one of the first randomized trials of fish oil in CAD, has been interpreted as potential support for fish oil’s role in sudden death reduction because the primary outcome of all-cause mortality occurred within 2 months of the trial’s onset.(38) After such a short time span,…”
BackgroundJELIS, fish oil, and cardiac events
Mozaffarian, D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60504-2 · Cited by 44 · cited 1×
“Overall, the findings were remarkable because at baseline approximately 90% of Japanese consumed at least 900 mg of EPA and DHA per day.(62) The rates of cancer, joint pain, lumbar pain, or muscle pain were similar in the 2 groups.”
BackgroundFisher, W. R., Zech, L. A., & Stacpoole, P. W. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33900-6 · Cited by 37
Roth, E. M., Bays, H. E., Forker, A. D., Maki, K. C., Carter, R., Doyle, R. T., & Stein, E. A. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181b0cf71 · Cited by 32 · cited 2×
“Therapy was well-tolerated without significant adverse reactions at 8 weeks or at the end of a 2-year open label extension.(64) The combination of fish oil and niacin requires further study.”
BackgroundJacobsen, A., Du, X., Dart, A. M., & Woodcock, E. A. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.273.3.h1119 · Cited by 26
Gosai, P., Liu, J., Doyle, R. T., Johnson, J., Carter, R., Sica, D. A., & McKenney, J. M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802532640 · Cited by 25
Remarks on clinical data concerning dietary supplements that affect antithrombotic therapy
Lichtenstein, A. H. (2005) · Thrombosis Research · doi:10.1016/j.thromres.2005.04.013 · Cited by 17
Reflections on the Diet and Reinfarction Trial (DART)
Burr, M. L. (2001) · European Heart Journal Supplements · doi:10.1016/s1520-765x(01)90124-5 · Cited by 10 · cited 1×
“Although the actual modes of death other than CAD-related deaths were not documented, it has been postulated to be secondary to a reduction in sudden death.(39) The Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico-Prevenzione(40) (GISSI-Prevenzione) trial, a larger randomized trial of fish oil…”
BackgroundEffects of Lipid-Altering Therapies on Ventricular Arrhythmias and Sudden Cardiac Death
Majmudar, M. D., TOMPKINS, C. M., Bachmann, J. M., Blumenthal, R. S., & Marine, J. E. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e3181861be8 · Cited by 8 · cited 1×
“The randomized trials assessing the efficacy of fish oil supplementation on secondary prevention of CAD lend further evidence to the findings that fish oil may protect from sudden cardiac death.(36) The Diet and Reinfarction Trial (DART),(37) one of the first randomized trials of fish oil in CAD, has been interpreted…”
Background
Research works printed but not linked: 1
- Frishman WH Sonnenblick EH Sica DA Cardiovascular Pharmacotherapeutics 2 New York, NY McGraw Hill 2003 382
Cited by
Microencapsulation of oils: A comprehensive review of benefits, techniques, and applications
Bakry, A. M., Abbas, S., Ali, B., Majeed, H., Abouelwafa, M. Y., Mousa, A., & Liang, L. (2016) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12179 · Cited by 918
Sokoła-Wysoczańska, E., Wysoczański, T., Wagner, J., Czyż, K., Bodkowski, R., Lochyński, S., & Patkowska-Sokoła, B. (2018) · Nutrients · doi:10.3390/nu10101561 · Cited by 360
“The fish oil and mustard oil groups showed a significant reduction in total cardiac arrhythmias, left ventricular enlargement, and angina pectoris compared to the placebo group [106].”
BackgroundMarine Omega-3 Phospholipids: Metabolism and Biological Activities
Burri, L., Hoem, N., Banni, S., & Berge, K. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131115401 · Cited by 257
Omega-3 fatty acid supplementation and cardiovascular disease
Jump, D. B., Depner, C. M., & Tripathy, S. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r027904 · Cited by 239
The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia
Backes, J., Anzalone, D., Hilleman, D., & Catini, J. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0286-4 · Cited by 195
“OM3FA dietary supplements are also available, but as these products do not need to comply with the rigorous regulations required for prescription formulations, and do not require approval from the FDA, their OM3FA content is often inconsistent and may be inadequate to effectively treat hypertriglyceridemia [25–27].”
Background
Metadata
- Authors
- Weitz, D., Weintraub, H., Fisher, E., & Schwartzbard, A. Z.
- Affiliations
- NYU Langone Health (US)
- Corresponding author
- Weitz, Daniel
- Venue
- Cardiology in Review
- Published
- 2010-09
- Volume
- 18
- Issue
- 5
- Pages
- 258-263
- ISSN
- 1061-5377 (ISSN-L)
- PMC
- PMC3217043
- OpenAlex
- W2036364822
- Cited by
- 138
- References
- 88
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 6 · 2023: 3 · 2022: 6 · 2021: 10 · 2020: 10 · 2019: 4 · 2018: 9 · 2017: 12 · 2016: 8 · 2015: 14 · 2014: 11 · 2013: 16 · 2012: 10
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cardiology in Review (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01 HL58541, R01HL058541)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Physical Sciences › Chemistry › Organic Chemistry › Edible Oils Quality and Analysis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- fish oil, omega-3 fatty acids, cardiovascular disease, triglyceride lowering, coronary artery disease, heart failure, cardiac arrhythmias, sudden cardiac death, myocardial infarction, plaque stability, diabetes mellitus, anti-inflammatory activity, lipid-lowering drugs, eicosapentaenoic acid, docosahexaenoic acid
- MeSH terms
- Hypolipidemic Agents, Arrhythmias, Cardiac, Cardiovascular Diseases, Diabetes Mellitus, Fish Oils, Heart Failure, Humans, Fenofibrate, Triglycerides, United States, Fatty Acids, Omega-3, Death, Sudden, Cardiac, Hydroxymethylglutaryl-CoA Reductase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.